Company / PP&E (Net)
Disc Medicine, Inc. PP&E (Net) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$1.2M
FY2025
5-year range
$106.0K / $1.2M
FY2021-FY2025
Trend
+54.3%
vs FY2024
Sector context
#152 of 193
Health Care
What the data says
Disc Medicine, Inc.'s pp&e (net) of $1M is lower than 79% of companies in the Health Care sector (FY2025). PP&E (Net) has increased for 4 consecutive years, from $106,000 in FY2021 to $1M in FY2025.
Based on SEC 10-K filings.
$1M in FY2025 with a 5-year CAGR of +31.6%.
Improved from $170,000 to $1M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- +90.4%
- 5-Year CAGR
- +31.6%
- 10-Year CAGR
- -
Sector benchmark
Bottom 21% in Health CareTop 79% of 193This company $1.2M Sector average $777.6M
▼
-99.9% below sector average
Key checks
Key Insights
- Disc Medicine, Inc.'s pp&e (net) has grown for 4 consecutive years.
- 5-year CAGR of +31.6%, indicating consistent growth.
- In FY2025, pp&e (net) increased 54.3% year-over-year.
- Ranks #152 out of 193 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score 4.41 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.2M | +54.3% |
| FY2024 | $751.0K | +341.8% |
| FY2023 | $170.0K | +1.2% |
| FY2022 | $168.0K | +58.5% |
| FY2021 | $106.0K | -63.9% |
| FY2020 | $294.0K | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026